Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX
Vaxcyte (PCVX) Stock Price & Analysis
126 Followers
PCVX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.44 - $54.84
Previous Close$48.97
Volume383.37K
Average Volume (3M)991.49K
Market Cap
$4.59B
Enterprise Value$3.78B
Total Cash (Recent Filing)$822.04M
Total Debt (Recent Filing)$16.59M
Price to Earnings (P/E)-14.1
Beta1.10
Next Earnings
Nov 07, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.46
Shares Outstanding93,706,790
10 Day Avg. Volume674,260
30 Day Avg. Volume991,486
Standard Deviation0.20
R-Squared0.07
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)5.11
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-25.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-14.76
Forecast
1Y Price Target
$66.67Price Target Upside36.14% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Vaxcyte News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PCVX FAQ
What was Vaxcyte, Inc.’s price range in the past 12 months?
Vaxcyte, Inc. lowest stock price was $17.44 and its highest was $54.84 in the past 12 months.
What is Vaxcyte, Inc.’s market cap?
Currently, no data Available
When is Vaxcyte, Inc.’s upcoming earnings report date?
Vaxcyte, Inc.’s upcoming earnings report date is Nov 07, 2023 which is in 163 days.
How were Vaxcyte, Inc.’s earnings last quarter?
Vaxcyte, Inc. released its earnings results on May 08, 2023. The company reported -$0.7 earnings per share for the quarter, beating the consensus estimate of -$0.822 by $0.122.
Is Vaxcyte, Inc. overvalued?
According to Wall Street analysts Vaxcyte, Inc.’s price is currently Undervalued.
Does Vaxcyte, Inc. pay dividends?
Vaxcyte, Inc. does not currently pay dividends.
What is Vaxcyte, Inc.’s EPS estimate?
Vaxcyte, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vaxcyte, Inc. have?
Vaxcyte, Inc. has 93,706,790 shares outstanding.
What happened to Vaxcyte, Inc.’s price movement after its last earnings report?
Vaxcyte, Inc. reported an EPS of -$0.7 in its last earnings report, beating expectations of -$0.822. Following the earnings report the stock price went down -0.992%.
Which hedge fund is a major shareholder of Vaxcyte, Inc.?
Among the largest hedge funds holding Vaxcyte, Inc.’s share is RA Capital Management. It holds Vaxcyte, Inc.’s shares valued at 273M.
---
Vaxcyte Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$66.67 (36.14% Upside)
$66.67 (36.14% Upside)
Blogger Sentiment
Bullish
PCVX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 639.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.1%
Last 30 Days ▲ 5.2%
Last 30 Days ▲ 5.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
89.36%
12-Months-Change
Fundamentals
Return on Equity
-37.56%
Trailing 12-Months
Asset Growth
150.34%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vaxcyte, Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from most common and deadly diseases.
---
Top 5 ETFs holding PCVX
Vanguard Health Care ETF
$10.24M
iShares NASDAQ US Biotechnology UCITS ETF
$2.20M
Fidelity MSCI Health Care Index ETF
$1.80M
First Trust US Equity Opportunities ETF
$1.59M
Fidelity Nasdaq Composite Index ETF
$896.11K
Up to five ETFs with an Outperform Smart Score that hold PCVX. The ETFs are listed according to market value of PCVX within the ETF
---
---